Literature DB >> 10489923

Development of a health-related quality-of-life questionnaire for individuals with gastroesophageal reflux disease: a validation study.

H H Colwell1, S D Mathias, D J Pasta, J M Henning, R H Hunt.   

Abstract

This study was conducted to test the psychometric properties of a newly developed health-related quality-of-life (HRQoL) questionnaire. A total of 172 symptomatic GERD patients completed a 57-item questionnaire (containing the SF-12; symptom frequency/bothersomeness; problems related to activities, sleep, work disability; overall HRQoL; and treatment satisfaction) at baseline, week 1 [retest (N = 25)], and week 4 [follow-up (N = 100)]. Internal-consistency reliability was acceptable for most scales (range: 0.74-0.92). Test-retest reliability was acceptable for most scales (ICC: 0.74-0.85). Construct validity was demonstrated based on observed correlations. Known-groups validity was upheld, as patients who experienced more symptom days and patients who reported higher pain reported worse HRQoL than those with less symptoms or less severe pain. When categorized according to change in pain severity, Guyatt's statistic for the "improved" and "worse" groups demonstrated responsiveness, although many of the scales for the "stable" group were also responsive. In conclusion, the HRQoL questionnaire was found to be reliable, valid, and responsive.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10489923     DOI: 10.1023/a:1026647701477

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

2.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.

Authors:  J Ware; M Kosinski; S D Keller
Journal:  Med Care       Date:  1996-03       Impact factor: 2.983

3.  Health-related quality of life of patients with acute erosive reflux esophagitis.

Authors:  S D Mathias; D O Castell; E P Elkin; M L Matosian
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

4.  Measuring change over time: assessing the usefulness of evaluative instruments.

Authors:  G Guyatt; S Walter; G Norman
Journal:  J Chronic Dis       Date:  1987

Review 5.  The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines.

Authors:  M B Fennerty; D Castell; A M Fendrick; M Halpern; D Johnson; P J Kahrilas; D Leiberman; J E Richter; R E Sampliner
Journal:  Arch Intern Med       Date:  1996-03-11

6.  Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.

Authors:  N I McDougall; B T Johnston; F Kee; J S Collins; R J McFarland; A H Love
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

7.  Methodological aspects of evaluation of Quality of Life in upper gastrointestinal diseases.

Authors:  E Dimenäs
Journal:  Scand J Gastroenterol Suppl       Date:  1993

Review 8.  Treatment of gastroesophageal (acid) reflux with lansoprazole: an overview.

Authors:  G Dobrilla; F Di Fede
Journal:  Clin Ther       Date:  1993       Impact factor: 3.393

9.  Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.

Authors:  D R Rush; W J Stelmach; T L Young; L J Kirchdoerfer; J Scott-Lennox; H E Holverson; S M Sabesin; T A Nicholas
Journal:  J Fam Pract       Date:  1995-08       Impact factor: 0.493

10.  Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Practice Parameters Committee of the American College of Gastroenterology.

Authors:  K R DeVault; D O Castell
Journal:  Arch Intern Med       Date:  1995-11-13
View more
  12 in total

Review 1.  Questionnaire based gastroesophageal reflux disease (GERD) assessment scales.

Authors:  V Pratap Mouli; Vineet Ahuja
Journal:  Indian J Gastroenterol       Date:  2011-07-23

2.  Health-Related quality-of-life and quality-days incrementally gained in symptomatic nonerosive GERD patients treated with lansoprazole or ranitidine.

Authors:  S D Mathias; H H Colwell; D P Miller; D J Pasta; J M Henning; J J Ofman
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

3.  Poorly treated or unrecognized GERD reduces quality of life in patients with COPD.

Authors:  Ivan E Rascon-Aguilar; Mark Pamer; Peter Wludyka; James Cury; Kenneth J Vega
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

4.  Psychometric documentation of a quality-of-life questionnaire for patients undergoing antireflux surgery (QOLARS).

Authors:  Zs Zéman; S Rózsa; T Tihanyi; E Tarkó
Journal:  Surg Endosc       Date:  2004-12-09       Impact factor: 4.584

Review 5.  Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literature.

Authors:  A M Rentz; C Battista; E Trudeau; R Jones; P Robinson; S Sloan; S Mathur; L Frank; D A Revicki
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 6.  Patient assessment of treatment satisfaction: methods and practical issues.

Authors:  D A Revicki
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

7.  Reasons for participating in randomised controlled trials: conditional altruism and considerations for self.

Authors:  Sharon K McCann; Marion K Campbell; Vikki A Entwistle
Journal:  Trials       Date:  2010-03-22       Impact factor: 2.279

Review 8.  The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature review.

Authors:  Manishi Prasad; Anne M Rentz; Dennis A Revicki
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

9.  Development of the Northwestern Esophageal Quality of Life Scale: A Hybrid Measure for Use Across Esophageal Conditions.

Authors:  Alyse Bedell; Tiffany H Taft; Laurie Keefer; John Pandolfino
Journal:  Am J Gastroenterol       Date:  2016-02-16       Impact factor: 10.864

10.  Long-term quality of life improvement in subjects with healed erosive esophagitis: treatment with lansoprazole.

Authors:  Thomas O Kovacs; James W Freston; Marian M Haber; Stuart Atkinson; Barbara Hunt; David A Peura
Journal:  Dig Dis Sci       Date:  2009-07-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.